Whose data set is it anyway? Sharing raw data from randomized trials
2006
The Importance of Sharing Raw Data from Clinical Trials
Commentary
Author Information
Author(s): Vickers Andrew J
Primary Institution: Memorial Sloan-Kettering Cancer Center
Hypothesis
Attitudes towards data sharing in the clinical trial community need to be rethought.
Conclusion
Data sharing should be seen as an inherent part of conducting a randomized trial to benefit patients.
Supporting Evidence
- Data sharing can help reproduce analyses and test secondary hypotheses.
- Sharing data may prevent fraud and selective reporting.
- Data sharing is common in other scientific fields, like genomics.
Takeaway
Researchers should share their data from clinical trials so that others can learn from it and improve future studies.
Potential Biases
Concerns about misrepresentation and being scooped may lead to reluctance in sharing data.
Limitations
The commentary does not provide specific empirical data or studies to support its claims.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website